Europe, Middle East & Africa
Accelerate clinical development with the IQVIA CORE
As science moves faster, research keeps pace
From emerging biotech firms to the largest global pharmaceutical companies, IQVIA's CORE-powered Clinical Development approach helps you match the pace of innovation with integrated solutions, and gives you the flexibility to match capabilities precisely with research needs.
We’re committed to providing solutions that help you innovate with confidence, maximize opportunities, and ultimately drive patient outcomes forward. The IQVIA CORE can connect you to innovative trial solutions like precision site selection, centralized monitoring, automated safety case processing and global regulatory expertise.
30% improvement
in non-enrolling sites with CORE-powered studies25% lower
Overall reduction in study costs vs. traditional trial execution2,500 data scientists
Including statisticians and analytic developers
R&D capabilities powered by the IQVIA CORE
- A global network of trial sites to optimize patient recruiting and research focus
- Advanced analytics leveraging machine learning and artificial intelligence
- Real world data to support enriched trials and innovative study design
- Regulatory knowledge across more than 100 global markets
- Digital enablement including virtual trials and synthetic study arms
The clinical trial and CRA of the future
Discover how risk-based and centralized monitoring can facilitate digital trial management and improve oversight, cost-effectiveness and patient safety.
Project management
2,500 data scientists
Including statisticians and analytic developersAssess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Access central labs around the globe through Q2 Solutions, a joint venture between IQVIA and Quest Diagnostics.